Page last updated: 2024-08-26
12-deoxyphorbolphenylacetate and HIV Coinfection
12-deoxyphorbolphenylacetate has been researched along with HIV Coinfection in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Blumberg, PM; Bocklandt, S; Hamer, DH | 1 |
Other Studies
1 other study(ies) available for 12-deoxyphorbolphenylacetate and HIV Coinfection
Article | Year |
---|---|
Activation of latent HIV-1 expression by the potent anti-tumor promoter 12-deoxyphorbol 13-phenylacetate.
Topics: Anti-HIV Agents; Carcinogens; CD4 Antigens; Cell Line; Down-Regulation; Gene Expression Profiling; HIV Infections; HIV-1; Humans; Macromolecular Substances; Models, Molecular; Oligonucleotide Array Sequence Analysis; Phorbol Esters; Protein Kinase C; Receptors, CXCR4; Virus Activation; Virus Replication | 2003 |